Holen Sie sich die Stockscreener-App
1.67
4.57%
-0.08
Schlusskurs vom Vortag:
$1.75
Offen:
$1.75
24-Stunden-Volumen:
214.87K
Relative Volume:
8.99
Marktkapitalisierung:
$8.39M
Einnahmen:
$5.54M
Nettoeinkommen (Verlust:
$-4.74M
KGV:
-4.9702
EPS:
-0.336
Netto-Cashflow:
$-750.60K
1W Leistung:
-7.22%
1M Leistung:
+9.15%
6M Leistung:
+4.18%
1J Leistung:
-16.33%
1-Tages-Spanne:
$1.66
$1.75
1-Wochen-Bereich:
$1.63
$1.85
52-Wochen-Spanne:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Firmenname
China Pharma Holdings Inc.
Sektor
Telefon
86 898 6681 1730
Adresse
No. 17, Jinpan Road, Second Floor, Haikou
Vergleichen Sie CPHI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.67 | 8.79M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
118.07 | 51.01B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.37 | 45.05B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.80 | 32.77B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.86 | 20.51B | 3.08B | 1.24B | 1.07B | 25.61 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2010-01-08 | Eingeleitet | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Aktie (CPHI) Neueste Nachrichten
China Pharma Holdings Acquires Patent in Stock Deal - TipRanks
China Pharma Holdings, Inc. (CPHI) Drops 7% in Pre-market: Despite No Clear Catalyst - Stocks Telegraph
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting - Yahoo Finance
Will China Pharma Holdings Inc. stock outperform value peersPortfolio Value Report & Growth Focused Entry Reports - Newser
Why China Pharma Holdings Inc. stock could see breakout soonTrade Signal Summary & Safe Capital Investment Plans - Newser
Can China Pharma Holdings Inc. stock surprise markets with earningsTrade Exit Summary & Technical Confirmation Trade Alerts - Newser
China Pharma Holdings Inc Stock Analysis and ForecastStock Buyback Updates & Free Stock Education Platform for New Investors - earlytimes.in
Morning Market Movers: PLRZ, PMI, CBIO, HY See Big Swings - RTTNews
How China Pharma Holdings Inc. (XQJ0) stock trades after rate cutsProfit Target & AI Based Trade Execution Alerts - Newser
How China Pharma Holdings Inc. stock valuations compare to rivalsTrend Reversal & Safe Capital Allocation Plans - Newser
Is China Pharma Holdings Inc. (XQJ0) stock vulnerable to rate hikesMarket Weekly Review & Momentum Based Trading Ideas - Newser
Why China Pharma Holdings Inc. stock is upgraded to buyTrade Analysis Summary & Free Technical Pattern Based Buy Signals - Newser
Why China Pharma Holdings Inc. stock is a must watch tickerQuarterly Risk Review & AI Optimized Trading Strategy Guides - Newser
Why institutional investors increase stakes in China Pharma Holdings Inc. (XQJ0) stock2025 Winners & Losers & Growth Focused Stock Pick Reports - Newser
What insider purchases suggest about China Pharma Holdings Inc. (XQJ0) stockGold Moves & Safe Capital Allocation Plans - Newser
Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025 - The Manila Times
Reviewing Graybug Vision (NASDAQ:GRAY) and China Pharma (NYSE:CPHI) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
What insider trading reveals about China Pharma Holdings Inc. stockMarket Trend Report & Daily Momentum Trading Reports - BỘ NỘI VỤ
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Why Keysight Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Earnings Chart Overlay Points to International Travel House Limited UpsideEarnings Revision Updates & Free Turn Volatility To Profit - earlytimes.in
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy - Yahoo Finance Singapore
Top 10 Prescription Drug Companies by Revenue in China - EssFeed
Why China Pharma Holdings Inc. stock could be next leaderGlobal Markets & Weekly Momentum Picks - newser.com
How China Pharma Holdings Inc. stock compares with top peersJuly 2025 Fed Impact & Smart Investment Allocation Tips - newser.com
Is China Pharma Holdings Inc. stock vulnerable to regulatory risksMarket Movers & Verified Technical Signals - newser.com
Can China Pharma Holdings Inc. (XQJ0) stock retain market dominanceTrade Analysis Summary & Verified Entry Point Detection - newser.com
Why China Pharma Holdings Inc. stock appears on watchlists2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Published on: 2025-11-20 06:20:45 - newser.com
Does China Pharma Holdings Inc. qualify in momentum factor screeningJuly 2025 Selloffs & Short-Term High Return Ideas - newser.com
How strong dollar benefits China Pharma Holdings Inc. stockFed Meeting & Daily Growth Stock Tips - newser.com
Why China Pharma Holdings Inc. stock is trending on social mediaIndex Update & Weekly Top Stock Performers List - newser.com
What momentum indicators show for China Pharma Holdings Inc. stock2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
Published on: 2025-11-20 00:39:09 - newser.com
Will China Pharma Holdings Inc. stock issue positive guidanceTrade Entry Summary & Daily Growth Stock Investment Tips - newser.com
Is China Pharma Holdings Inc. stock a buy for dividend portfoliosWeekly Trend Report & AI Powered Market Entry Ideas - newser.com
How supply shortages influence China Pharma Holdings Inc. (XQJ0) stock2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Finanzdaten der China Pharma Holdings Inc.-Aktie (CPHI)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.87%
4.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):